Giovanni Cazzaniga

1992–2025 年に発表

109
論文数
17,906
被引用数
69
h 指数
104
i10 指数

被引用数

Giovanni Cazzaniga の年別被引用数1993 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 7 件1996 年: 被引用 2 件1997 年: 被引用 7 件1998 年: 被引用 11 件1999 年: 被引用 22 件2000 年: 被引用 48 件2001 年: 被引用 44 件2002 年: 被引用 60 件2003 年: 被引用 71 件2004 年: 被引用 60 件2005 年: 被引用 89 件2006 年: 被引用 88 件2007 年: 被引用 91 件2008 年: 被引用 110 件2009 年: 被引用 145 件2010 年: 被引用 128 件2011 年: 被引用 104 件2012 年: 被引用 208 件2013 年: 被引用 143 件2014 年: 被引用 157 件2015 年: 被引用 200 件2016 年: 被引用 163 件2017 年: 被引用 174 件2018 年: 被引用 138 件2019 年: 被引用 511 件2020 年: 被引用 511 件2021 年: 被引用 606 件2022 年: 被引用 405 件2023 年: 被引用 323 件2024 年: 被引用 517 件2025 年: 被引用 181 件2026 年: 被引用 1 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,457 件、この内訳の 21.3%ドイツ: 引用元論文 651 件、この内訳の 9.5%イタリア: 引用元論文 554 件、この内訳の 8.1%イギリス: 引用元論文 553 件、この内訳の 8.1%フランス: 引用元論文 346 件、この内訳の 5.1%オランダ: 引用元論文 324 件、この内訳の 4.7%中国: 引用元論文 296 件、この内訳の 4.3%スペイン: 引用元論文 209 件、この内訳の 3%オーストラリア: 引用元論文 205 件、この内訳の 3%カナダ: 引用元論文 181 件、この内訳の 2.6%スイス: 引用元論文 162 件、この内訳の 2.4%スウェーデン: 引用元論文 159 件、この内訳の 2.3%
0%21.3%その他 25.6%

分野

  • Medicine75%
  • Biochemistry, Genetics and Molecular Biology20%
  • Immunology and Microbiology3.8%
  • Environmental Science0.2%
  • Neuroscience0.2%
  • Energy0.2%
  • その他0.6%

トピック

  • Acute Lymphoblastic Leukemia research14.9%
  • Acute Myeloid Leukemia Research11.4%
  • Chronic Myeloid Leukemia Treatments6.7%
  • Childhood Cancer Survivors' Quality of Life5%
  • Lymphoma Diagnosis and Treatment3.6%
  • CAR-T cell therapy research3.4%
  • その他55%

共著者

全論文

検索で開く
  1. The KMT2A recombinome of acute leukemias in 2023

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julia Mason, R. Price, J. Kim, Cornelia Eckert, Luca Lo Nigro, Clara Bueno, Pablo Menéndez, Udo zur Stadt, Paula Gameiro, Łukasz Sędek, Tomasz Szczepański, Audrey Bidet, Victoria Malina -Marcu, Keren Shichrur, Shai Izraeli, H O Madsen, Beat W. Schäfer, Susanne Kubetzko, Rathana Kim, Emmanuelle Clappier, Heiko Trautmann, Monika Brüggemann, Paul A. Archer, Jerry Hancock, Julia Alten, Anja Möricke, Martin Stanulla, Jana Lentes, Anke K. Bergmann, Sabine Strehl, Stefan Köhrer, Karin Nebral, Michael Dworzak, Oskar A. Haas, Chloé Arfeuille, Aurélie Caye‐Eude, Hélène Cavé, Rolf Marschalek - Leukemia 2023 被引用: 216

  2. Sleeping Beauty–engineered CAR T cells achieve antileukemic activity without severe toxicities

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2020 被引用: 188

  3. The MLL recombinome of acute leukemias in 2017

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yulia Olshanskaya, Clara Bueno, Pablo Menéndez, Andrea Teigler‐Schlegel, Udo zur Stadt, Jana Lentes, Gudrun Göhring, Anatoly Kustanovich, Olga Aleinikova, Beat W. Schäfer, Susanne Kubetzko, H O Madsen, Bernd Gruhn, Ximo Duarte, Paula Gameiro, Éric Lippert, Audrey Bidet, J M Cayuela, Emmanuelle Clappier, Cristina N. Alonso, C. Michel Zwaan, Marry M. van den Heuvel‐Eibrink, Shai Izraeli, L. Trakhtenbrot, Paul A. Archer, Jerry Hancock, Anja Möricke, Julia Alten, Martin Schrappe, Martin Stanulla, Sabine Strehl, Andishe Attarbaschi, Michael Dworzak, Oskar A. Haas, R Panzer-Grümayer, Łukasz Sędek, Tomasz Szczepański, Aurélie Caye, Lydia Suarez, Hélène Cavé, Rolf Marschalek - Leukemia 2017 被引用: 686

  4. IKZF1plusDefines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Doris Steinemann, Oskar A. Haas, Renate Panzer‐Grümayer, Hélène Cavé, Richard S. Houlston, Gunnar Cario, Martin Schrappe, Martin Zimmermann, the International BFM Study Group - Journal of Clinical Oncology 2018 被引用: 299

  5. Metabolic gatekeeper function of B-lymphoid transcription factors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2017 被引用: 244

  6. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

    著者: , , , , , , , , , , , , , , , , , , , - Leukemia 2003 被引用: 1,528

  7. Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patricia J.T.A. Groenen, Michael Hummel, Elizabeth Macintyre, Κώστας Σταματόπουλος, Christiane Pott, Jan Trka, Nikos Darzentas, Anton W. Langerak - Leukemia 2019 被引用: 261

  8. Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data

    著者: , , , , , , , , , , , , , , , , , , , - Leukemia 2007 被引用: 700

  9. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2010 被引用: 786

  10. Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2016 被引用: 285

  11. An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Farhad Ravandi, Hagop M. Kantarjian, Stephen D. Nimer, Konstanze Döhner, Hartmut Döhner, Timothy J. Ley, Paola Ballerini, Sheila Shurtleff, Daisuke Tomizawa, Souichi Adachi, Yasuhide Hayashi, Akio Tawa, Lee‐Yung Shih, Der-Cherng Liang, Jeffrey E. Rubnitz, Ching‐Hon Pui, Elaine R. Mardis, Richard K. Wilson, James R. Downing - Cancer Cell 2012 被引用: 276

  12. Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2022 被引用: 61

  13. Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2020 被引用: 66

  14. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2011 被引用: 438

  15. Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Blood 2021 被引用: 74

  16. Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2023 被引用: 39

  17. Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2013 被引用: 178

  18. Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2021 被引用: 82

  19. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan Zuna, Helena Kempski, Markus Müschen, Anthony M. Ford, Michael R. Stratton, Mel Greaves, Peter J. Campbell - Nature Genetics 2014 被引用: 397

  20. Gain-of-function mutations in interleukin-7 receptor-α ( IL7R ) in childhood acute lymphoblastic leukemias

    著者: , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2011 被引用: 348

  21. The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia

    著者: , , , - International Journal of Molecular Sciences 2021 被引用: 81

  22. Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders.

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Monika Brüggemann, Christiane Pott, Anton W Langerak, David Gonzalez - 2021 被引用: 51

  23. IKZF1 status as a prognostic feature in BCR-ABL1–positive childhood ALL

    著者: , , , , , , , , , , , , , , , - Blood 2013 被引用: 150

  24. Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia

    著者: , , , , , , , , , , , , , , , , , , , , , - Leukemia 2012 被引用: 115